Source: Commercial Property Executive

IPS: IPS, Meyer Deliver $800M Biopharma R&D Project

This marks one of the country's largest investments in biopharmaceutical manufacturing. The post IPS, Meyer Deliver $800M Biopharma R&D Project appeared first on Commercial Property Executive.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Jim Stephanou's photo - CEO of IPS

CEO

Jim Stephanou

CEO Approval Rating

82/100

Read more